EN DE

Shanghai Chemspec Corporation (688602) Fair Value & Analysis

Basic Materials · CN · Market cap 3.9B CNY

SC Shanghai Chemspec Corporation 688602 · SHG
Price¥6.61
Fair Value¥10.58
Upside+60.0%
Quality42/100
Watch Shanghai Chemspec Corporation for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -15.9% net margin
Low debt · generates free cash flow
Trails peers (4/11)
Narrow moat 17/100
Evidence: Medium Range ¥8.96 – ¥12.19 Share as image

Fair value as of: Jul 12, 2026

From 12 valuation models · updated 29 days ago

Fair value updated Jul 12, 2026, revised from ¥5.56 to ¥10.58 (+90.2%) since Jun 24, 2026. Share price −10.4% over the past month.

Below-average quality, screening 60% undervalued on our models.

What matters now

  • The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain.
  • The price is below even our cautious bear case (¥8.96). The market is more pessimistic than our downside scenario.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (3 years)

¥15.65 ¥5.69 Fair Value ¥10.58 Jul 2023 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.

How to read this chart

37‑month range ¥5.69 – ¥15.65 · fair‑value band ¥8.96 – ¥12.19 · the ¥6.61 price screens below the ¥10.58 fair value. Dashed = 300-day average. As of Jul 12, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Shanghai Chemspec Corporation (688602) currently trades at ¥6.61, while our model-based Fair Value estimate is ¥10.58, implying the stock looks roughly 60.0% undervalued today. The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Shanghai Chemspec Corporation generated revenue of 676M CNY at a net margin of -15.9%. Revenue declined 38.4% year over year. It earns a return on equity of -3.9%. Fundamentals as of Jul 12, 2026

Our scenario range runs from ¥8.96 (bear case) to ¥12.19 (bull case); at ¥6.61, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 49% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at 60%, 688602 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF ¥2.38 ¥2.45 ¥2.58 80
Rev-Margin DCF ¥2.35 ¥2.45 ¥2.57 74
Gordon GGM ¥0.0800 ¥0.0900 ¥0.1000 70
All 12 models by family
DCF Models
FCF DCF ¥2.37 ¥2.45 ¥2.59 38
5Y Revenue Exit ¥2.35 ¥2.45 ¥2.58 39
5Y EBITDA Exit ¥3.55 ¥4.52 ¥5.80 41
10Y Revenue Exit ¥2.35 ¥2.42 ¥2.49 36
10Y EBITDA Exit ¥3.07 ¥3.67 ¥4.34 37
Dividend Discount
Gordon GGM ¥0.0800 ¥0.0900 ¥0.1000 70
DDM Multi-Stage ¥0.0800 ¥0.1000 ¥0.1300 61
Multiples
EV/EBITDA ¥4.71 ¥5.56 ¥6.41 54
EV/Revenue ¥2.36 ¥2.46 ¥2.55 43
Asset-Based
NCAV (Graham) ¥2.62 ¥3.50 ¥5.23 50
Growth DCF
Growth DCF ¥2.38 ¥2.45 ¥2.58 80
Rev-Margin DCF ¥2.35 ¥2.45 ¥2.57 74

Widest divergence: Asset-Based (¥3.50) versus Dividend Discount (¥0.0900). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 676M CNY
Revenue growth (YoY) -38.4%
Net margin -15.9%
Return on equity -3.9%
Free cash flow 12.3M CNY FY2025
Operating margin -13.5%
More key figures
EPS (TTM) ¥-0.2000

Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 42/100

Of which business quality 46 · Market factors (momentum, volatility) 27

Profitability 7
Margins and returns on capital today
Quality Growth 65
Are margins and returns improving?
Cashflow 29
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 38
Disciplined investing over empire-building
Low Volatility 63
Calm price path (market factor)
Momentum 17
Price trend over the last 3–12 months (market factor)
52W Momentum 4
Distance to the 52-week high (market factor)
Net Issuance 40
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Shanghai Chemspec Corporation engages in the research, development, production, and sale of fine chemicals. It offers display material, new energy battery material, silicon and organosilicon materials, electronic chemical, functional materials, other special chemicals. The company also provides pharmaceutical and pesticide chemicals.

Full company description

Shanghai Chemspec Corporation engages in the research, development, production, and sale of fine chemicals. It offers display material, new energy battery material, silicon and organosilicon materials, electronic chemical, functional materials, other special chemicals. The company also provides pharmaceutical and pesticide chemicals. The company was founded in 1996 and is headquartered in Shanghai, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Shanghai Chemspec Corporation reported revenue of ¥770M in FY2025 versus ¥1.0B in FY2021, a compound −6.4%/yr. Reported net income was −¥64.2M in FY2025.

Growth Quality 24/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
770M CNY
Latest YoY
+14.0%
Avg. growth/yr (3Y)
−14.7%
Revenue −6.4%/yr
FY21 ¥1.0B
FY22 ¥1.2B
FY23 ¥980M
FY24 ¥675M
FY25 ¥770M
Net income
FY21 ¥134M
FY22 ¥181M
FY23 ¥113M
FY24 −¥49.5M
FY25 −¥64.2M

Watch 688602: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Shanghai Chemspec Corporation Fair Value". https://www.fairvalue-calculator.com/stock/688602

Peer Group

Chemicals · 334 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 42 · Below median
Fair Value upside +60% · Top 25%
Return on assets -3% · Bottom 25%
Net margin (TTM) -16% · Bottom 25%
Operating margin (TTM) -13% · Bottom 25%
Revenue growth -38% · Bottom 25%
Debt / equity 0.03× · Lower than median

Valuation Multiples vs Chemicals median · lower = cheaper

P/B 0.21× · Cheaper than 75% of peers
P/S (TTM) 0.86× · Cheaper than median
P/FCF 47.3× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 0
FUTURE 0 · sector 20
PAST 0 · sector 19
HEALTH 99 · sector 94
DIVIDEND 0 · sector 27

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare Shanghai Chemspec Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Shanghai Chemspec Corporation (688602) overvalued or undervalued?
As of Jul 12, 2026, our model estimates a fair value of ¥10.58 versus a price of ¥6.61, about +60% (undervalued).
What is the fair value of 688602?
Our model-based fair value for Shanghai Chemspec Corporation is ¥10.58 (as of Jul 12, 2026), built from audited fundamentals. The current price is ¥6.61.
What is the quality score of 688602?
Shanghai Chemspec Corporation has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Shanghai Chemspec Corporation (688602)?
Shanghai Chemspec Corporation reported trailing-twelve-month revenue of about 676M CNY (latest available figure, as of Jul 12, 2026).
What is the net profit margin of 688602?
The net profit margin of Shanghai Chemspec Corporation is about -15.9%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Shanghai Chemspec Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.